Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 38.258M	--
--	2025/Q1	-- / 31.803M	--
Feb 25, 2025	2024/Q4	29.200M / 27.790M	--
Oct 30, 2024	2024/Q3	93.761M / 28.451M	--
Jul 30, 2024	2024/Q2	8.192M / 912.220K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 38.258M--

--2025/Q1-- / 31.803M--

Feb 25, 20252024/Q429.200M / 27.790M--

Oct 30, 20242024/Q393.761M / 28.451M--

Jul 30, 20242024/Q28.192M / 912.220K--

Unlock Free Earnings Estimates

Open Account

Day One Biopharmaceuticals | 10-K: FY2024 Annual Report

Feb 25 16:12 ET

Day One Biopharmaceuticals | 8-K: Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

Feb 25 16:07 ET

Day One Biopharmaceuticals | 10-Q: Q3 2024 Earnings Report

Oct 30, 2024 16:07 ET

Day One Biopharmaceuticals | 8-K: Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

Oct 30, 2024 16:03 ET

DAWN Day One Biopharmaceuticals

Day One Biopharmaceuticals Key Stats